Humanigen (OTCMKTS:HGEN) Lowered to “Hold” at ValuEngine

Share on StockTwits

ValuEngine lowered shares of Humanigen (OTCMKTS:HGEN) from a buy rating to a hold rating in a research report sent to investors on Friday, ValuEngine reports.

OTCMKTS HGEN opened at $1.06 on Friday. Humanigen has a 1-year low of $0.27 and a 1-year high of $1.54.

About Humanigen

Humanigen, Inc, a biopharmaceutical company, engages in developing its proprietary monoclonal antibodies for immunotherapy and oncology treatments. The company's products include lenzilumab and ifabotuzumab, which are monoclonal antibodies derived from Humaneered platform. Lenzilumab targets granulocyte-macrophage colony-stimulating factor (GM-CSF), and is in development as a potential medicine for chimeric antigen receptor T cell (CAR-T) therapy, as well as a potential treatment for rare hematologic cancers, such as chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML).

Read More: What are popular range trading strategies?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Humanigen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humanigen and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Wheeler Real Estate Investment Trust  Shares Cross Below Two Hundred Day Moving Average of $0.00
Wheeler Real Estate Investment Trust Shares Cross Below Two Hundred Day Moving Average of $0.00
Baskerville Capital  Sets New 1-Year High at $4.55
Baskerville Capital Sets New 1-Year High at $4.55
Wheeler Real Estate Investment Trust  Shares Cross Below Two Hundred Day Moving Average of $0.00
Wheeler Real Estate Investment Trust Shares Cross Below Two Hundred Day Moving Average of $0.00
Baskerville Capital  Sets New 1-Year High at $4.55
Baskerville Capital Sets New 1-Year High at $4.55
Boston Therapeutics  Share Price Crosses Below 200-Day Moving Average of $0.00
Boston Therapeutics Share Price Crosses Below 200-Day Moving Average of $0.00
Gamco Natural Resources Gold & Incm Trst  Share Price Passes Below 200-Day Moving Average of $0.00
Gamco Natural Resources Gold & Incm Trst Share Price Passes Below 200-Day Moving Average of $0.00


 
© 2006-2019 Zolmax.